INTRODUCTION
Ischemia/reperfusion injury, which results from the interruption of blood flow and subsequent organ reperfusion, contributes to graft dysfunction and acute graft rejection; it is, therefore, a major problem in clinical organ transplantation. [1] [2] [3] Oxidative stress and compromised energy metabolism are associated, at least in part, with ischemia/reperfusion injury. [4] [5] [6] [7] To inhibit this, organ preservation solutions such as Euro-Collins solution and University of Wisconsin solution are used. [8] [9] [10] These solutions are generally composed of electrolytes and buffers, with carbohydrates such as glucose and trehalose added to prevent energy loss. In addition, to inhibit the generation of reactive oxygen species during cold preservation and ischemia/reperfusion, the anti-oxidant glutathione (GSH) is added to the University of Wisconsin solution. [11] [12] [13] Although they are essential for clinical transplantation, there are several disadvantages to these solutions, including chemical instability and high viscosity. Also, they are not cost-effective for short-term storage. 14) Therefore, a new, effective reagent for organ preservation is critical.
Phosphoenolpyruvate (PEP) is an intermediate of glycolysis and gluconeogenesis that contains a high-energy phosphate bond. PEP can penetrate the cell membrane and transfer its high-energy phosphate group to adenosine 5 -diphosphate (ADP) to replenish intracellular ATP levels. 15, 16) It has been reported that PEP improves the energy status of the heart 17, 18) and skeletal muscle 19) after ischemia, and of the liver after ischemia-reperfusion. 15) Hojo et al. 20) demonstrated that the survival of transplanted kidney grafts was improved by Euro-Collins solution containing 10 mM PEP in a canine experimental kidney transplantation model. However, little is known about the precise mechanism underlying the protective effects of PEP and there is no evidence that PEP has the potential to attenuate cellular injury induced by oxidative stress, or dysfunctions in energy metabolism, which play important roles in ischemia/reperfusion injury.
Based on these facts, we designed an in vitro experiment to examine the effects of PEP on cellular injury induced by hydrogen peroxide (H 2 O 2 ) or the glycolysis inhibitor, 2-deoxy-D-glucose (2-DG), in the porcine proximal kidney tubular cell line, LLC-PK 1 . To evaluate the usefulness of PEP as an organ preservation agent, we compared the anti-oxidative effects of PEP with that of other components used in organ preservation solutions, such as glucose, trehalose and GSH.
MATERIALS AND METHODS
Materials --Sodium phosphoenolpyruvate monohydrate was kindly donated by Ube Kousan (Yamaguchi, Japan). H 2 O 2 and 2-DG were purchased from Wako Pure Chemicals (Osaka, Japan). The Cell Counting Kit was obtained from Dojindo Laboratories (Kumamoto, Japan). Medium 199 Earle's (M199) was obtained from Invitrogen Japan (Tokyo, Japan). Fetal bovine serum (FBS) was purchased from Thermo Scientific HyClone (Logan, UT, U.S.A.). All other reagents and solvents were of reagent grade. De-ionized and distilled bio-pure grade water was used throughout the study. Cell Culture --The LLC-PK 1 cell line was obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). LLC-PK 1 cells were cultured in M199 supplemented with 3% FBS, 100 IU/ml of penicillin, 100 µg/ml streptomycin at 37 • C and 5% CO 2 . Confluent cultures were washed with phosphate-buffered saline (PBS) pH 7.4, detached with EDTA and trypsin, centrifuged and subcultured in 96-well plates. Cells were seeded at a density of 1 × 10 4 cells/well and grown on culture dishes for 24 hr before use in the cell viability experiments. Cell Viability Assays --To evaluate the viability of LLC-PK 1 cells, mitochondrial dehydrogenase activity was measured using a modified MTT assay (the WST-1 assay) and the Cell Counting Kit according to the manufacturer's protocol. Cells were incubated with either H 2 O 2 or 2-DG at 37 • C and 5% CO 2 and the cell viability was assessed after 24 hr. In a preliminary study, we determined the minimum concentrations of H 2 O 2 and 2-DG that induced a decrease in cell viability with high reproducibility and optimal concentrations were chosen for treatment. Based on the results, we used H 2 O 2 or 2-DG at concentrations of 0.1 mM and 15 mM, respectively. To evaluate the effects of PEP on cell viability, PEP was used at doses up to 10 mM, as the maximum non-cytotoxic dose in LLC-PK 1 cells was 20 mM (data not shown). Measurement of Hydrogen Peroxide Decomposition --We prepared a reaction mixture containing: 0.1 mM H 2 O 2 , 120 mM KCl and 50 mM TrisHCl, pH 7.4 and then added PEP (0.1-10 mM) to the mixture. The reaction was allowed to proceed for 30 min at 37.8 • C and terminated by the addition of a stop solution (25 mg/ml potassium biphthalate, 2.5 mg/ml NaOH, 82.5 mg/ml potassium iodide, and 0.25 mg/ml ammonium molybdate). The absorbance of the mixture was measured at 350 nm in a spectrophotometer (V-530; Jasco, Tokyo, Japan) and the concentration of H 2 O 2 was determined by interpolation of the data using a standard curve. Statistical Analysis --Results were expressed as mean ± S.D. Multiple comparisons were made to examine the statistical significance of the data. When uniform variance was identified by Bartlett's analysis (p < 0.05), one-way analysis of variance (ANOVA) was used to test for statistical significance. When significant differences (p < 0.05) were identified the data were further analyzed using Tukey's multiple range test.
RESULTS

Effects of PEP Treatment on the Decrease in Cell
Viability Induced by H 2 O 2 or 2-DG in LLC-PK 1 Cells LLC-PK 1 cells treated with 0.1 mM H 2 O 2 for 24 hr showed a 67% decrease in cell viability compared with the control (Fig. 1A) . When 0.5-10 mM PEP was added to the culture medium just after H 2 O 2 treatment, the decrease in cell viability induced by H 2 O 2 was significantly attenuated in a dose-dependent manner (Fig. 1A) .
As shown in Fig. 1B , treatment with 15 mM 2-DG for 24 hr significantly reduced cell viability (to approximately 60% of the value of the control group). This decrease in viability was significantly attenuated by PEP (10 mM, to approximately 87% of the value of the control group). 
Evaluation of PEP-mediated H 2 O 2 Decomposition
As shown in Fig. 2 , treatment with PEP significantly reduced the H 2 O 2 content of the reaction mixture, which was completely abolished by PEP at concentrations ≥ 5 mM. To compare the ability of PEP to degrade H 2 O 2 with that of the components of Euro-Collins or University of Wisconsin organ preservation solutions (such as glucose, trehalose and GSH) we determined the concentration of each reagent required to yield 50% decomposition of 0.1 mM H 2 O 2 (50% effective concentration, EC 50 ). The EC 50 value for PEP was 0.26 mM compared with 200 and 120 mM (close to the concentrations used for organ preservation) for glucose and trehalose, respectively. The EC 50 of GSH and Nacetylcysteine (NAC), also used as antioxidants for organ preservation, were 0.07 and 0.02 mM, respectively.
Effects of PEP and Other Components in Organ Preservation Solutions on H 2 O 2 -induced Cellular Injury in LLC-PK 1 Cells
Glucose (194 mM) and trehalose (120 mM, the concentrations used in organ preservation solutions) had little effect in preventing the H 2 O 2 -mediated decrease in cell viability (Fig. 3) . However, this decrease in viability was significantly abrogated by PEP (10 mM), GSH (3 mM) and NAC (10 mM, Fig. 3) . 
DISCUSSION
In this study, we showed that PEP, an intermediate of glycolysis, protected LLC-PK 1 cells from injury induced by H 2 O 2 and 2-DG. PEP was also able to mediate the decomposition of H 2 O 2 These results indicate that PEP protects against cellular injury induced by oxidative stress and against dysfunctions in carbohydrate metabolism through, at least in part, an antioxidant effect.
Ischemia/reperfusion of allografts triggers oxidative stress leading to dysfunction and acute rejection. 2) The xanthine oxidase system is activated during ischemia/reperfusion and increased levels of H 2 O 2 and hydroxyl radicals (decomposition products of H 2 O 2 ) can injure the allograft; thus, H 2 O 2 -induced renal cell injury has frequently been used as an in vitro model of ischemia/reperfusion injury in the kidney. 21, 22) The results of our current in vitro study support those from in vivo studies showing that PEP improves energy status and improves the function and survival of allografts. 20) Our results also indicate that PEP protects allografts from acute rejection, not only through improved ATP levels, but also via its antioxidant effects.
PEP contains a high-energy phosphate group and efficiently supplies energy to ischemic/ reperfused organs in vivo and in situ 15, [17] [18] [19] [20] Our current results suggest that the in vitro protective effects of PEP against cellular injury induced by the glycolysis inhibitor, 2-DG, used as an in vitro model of ischemic organ injury due to energy metabolism dysfunction, 21) may be due to the fact that PEP replenishes cellular ATP and acts as a cytoprotective agent against energy metabolism dysfunctions.
The protective effects of PEP against cellular injury mediated by oxidative stress and dysfunctions in carbohydrate metabolism protect allografts and organs from ischemia/reperfusion injury. Antioxidants are frequently used in organ preservation solutions to protect tissues from oxidative stress induced during preservation and ischemia/reperfusion. 8, 12) University of Wisconsin solution contains glutathione and allopurinol, whereas ET-Kyoto solution contains NAC. These preservation solutions seem to achieve better results than other preservation solutions. 23, 24) In addition, carbohydrates such as glucose and trehalose are added to preservation solutions to reduce energy depletion from organs/cells during preservation. PEP may be an attractive bifunctional carbohydrate with the potential to act as both energy supplier and antioxidant. To establish the efficacy of PEP as a component of organ preservation solutions, it is important to identify its effects on other causes of allograft dysfunction, such as cold preservation and rewarming of the cells and organs and immune responses/inflammatory reactions. 25) In addition, it is important to clarify whether PEP-containing organ preservation solutions are safe for both the allograft and the recipient. Further studies are therefore warranted.
In summary, we have shown that PEP protected LLC-PK 1 cells against injury induced by H 2 O 2 and 2-DG and facilitated the decomposition of H 2 O 2 . The results suggest that PEP is a bifunctional carbohydrate with antioxidant effects and has potential for use as an agent for organ preservation in clinical transplantation.
